Q2 FY2025 6.6% Year on Year Revenue
Increase to £195.6 million 9.1% Revenue Increase at Constant
Currency Diluted EPS £0.11 compared to £0.14 in the prior
comparative period Adjusted Diluted EPS £0.30 unchanged from
the prior comparative period Endava announces $100 million
share repurchase program
Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading
technology services company combining world-class engineering,
industry expertise and a people-centric mindset, today announced
results for the three months ended December 31, 2024, the second
quarter of its 2025 fiscal year ("Q2 FY2025").
"Our results for the second quarter of FY25 were solid with
improved profitability. Gen AI adoption is becoming a key priority
for clients. With our hands-on experience, coupled with deep
industry expertise, we believe we are in a strong position to cut
through the hype that our clients are exposed to regarding AI and
to work with them to deliver real business value. Additionally,
today, we announced our first share buyback program totaling $100
million as we reinforce our commitment to optimising our capital
allocation," said John Cotterell, Endava's CEO.
SECOND QUARTER FISCAL YEAR 2025 FINANCIAL HIGHLIGHTS:
- Revenue for Q2 FY2025 was £195.6 million, an increase of 6.6%
compared to £183.6 million in the same period in the prior
year.
- Revenue increase at constant currency (a non-IFRS measure)* was
9.1% for Q2 FY2025.
- Profit before tax for Q2 FY2025 was £2.5 million, compared to
£10.6 million in the same period in the prior year.
- Adjusted profit before tax (a non-IFRS measure)* for Q2 FY2025
was £21.8 million, or 11.2% of revenue, compared to £22.7 million,
or 12.4% of revenue, in the same period in the prior year.
- Profit for the period was £6.9 million, resulting in a diluted
earnings per share ("EPS") of £0.11, compared to profit of £8.3
million and diluted EPS of £0.14 in the same period in the prior
year.
- Adjusted profit for the period (a non-IFRS measure)* was £17.9
million, resulting in adjusted diluted EPS (a non-IFRS measure)* of
£0.30, compared to adjusted profit for the period of £17.5 million
and adjusted diluted EPS of £0.30 in the same period in the prior
year.
CASH FLOW:
- Net cash from operating activities was £32.0 million in Q2
FY2025, compared to net cash from operating activities of £35.0
million in the same period in the prior year.
- Adjusted free cash flow (a non-IFRS measure)* was £31.6 million
in Q2 FY2025, compared to £33.6 million in the same period in the
prior year.
- At December 31, 2024, Endava had cash and cash equivalents of
£60.1 million, compared to £62.4 million at June 30, 2024.
* Definitions of the non-IFRS measures used by the Company and a
reconciliation of such measures to the related IFRS financial
measure can be found under the sections below titled “Non-IFRS
Financial Information” and “Reconciliation of IFRS Financial
Measures to Non-IFRS Financial Measures.”
OTHER METRICS FOR THE QUARTER ENDED DECEMBER 31,
2024:
- Headcount totaled 11,668 at December 31, 2024, with an average
of 10,456 operational employees in Q2 FY2025, compared to a
headcount of 11,539 at December 31, 2023 and an average of 10,461
operational employees in the same period in the prior year.
- Number of clients with over £1 million in revenue on a rolling
twelve-month basis was 141 at December 31, 2024, compared to 150
clients at December 31, 2023.
- Top 10 clients accounted for 36% of revenue in Q2 FY2025,
compared to 34% in the same period in the prior year.
- By geographic region, 39% of revenue was generated in North
America, 24% was generated in Europe, 32% was generated in the
United Kingdom and 5% was generated in the rest of the world in Q2
FY2025. This compares to 31% in North America, 26% in Europe, 34%
in the United Kingdom and 9% in the Rest of the World in the same
period in the prior year.
- By industry vertical, 19% of revenue was generated from
Payments, 19% from BCM, 9% from Insurance, 19% from TMT, 9% from
Mobility, 12% from Healthcare, and 13% from Other in Q2 FY2025.
This compares to 26% from Payments, 14% from BCM, 8% from
Insurance, 23% from TMT, 11% from Mobility, 4% from Healthcare, and
14% from Other in the same period in the prior year.
OUTLOOK:
Third Quarter Fiscal Year 2025:
Endava expects revenue will be in the range of £198.0 million to
£200.0 million, representing a constant currency revenue increase
of between 13.0% and 14.0% on a year over year basis. Endava
expects adjusted diluted EPS to be in the range of £0.31 to £0.32
per share.
Full Fiscal Year 2025:
Endava expects revenue will be in the range of £795.0 million to
£800.0 million, representing a constant currency revenue increase
of between 8.5% and 9.0% on a year over year basis. Endava expects
adjusted diluted EPS to be in the range of £1.20 to £1.23 per
share.
This above guidance for the third quarter and full fiscal year
2025 assumes the exchange rates on January 31, 2025 (when the
exchange rate was 1 British Pound to 1.24 US Dollar and 1.20
Euro).
Endava is not able, at this time, to reconcile its expectations
for the third quarter and full fiscal year 2025 for a rate of
revenue growth or decline at constant currency or adjusted diluted
EPS to their respective most directly comparable IFRS measures as a
result of the uncertainty regarding, and the potential variability
of, reconciling items such as share-based compensation expense,
amortisation of acquired intangible assets, foreign currency
exchange losses / (gains), net, and fair value movement of
contingent consideration, as applicable. Accordingly, a
reconciliation is not available without unreasonable effort,
although it is important to note that these factors could be
material to Endava's results computed in accordance with IFRS.
The guidance provided above is forward-looking in nature. Actual
results may differ materially. See “Forward-Looking Statements”
below.
SHARE REPURCHASE PROGRAM:
Endava's Board of Directors has approved a share repurchase
program authorizing the Company to repurchase up to $100 million of
its Class A ordinary shares (in the form of American Depositary
Shares) as part of Endava’s evolving approach to capital
allocation. As Endava is a UK-incorporated company, execution of
the share repurchase program is subject to shareholder approval,
which we intend to seek at a general meeting to be held on or
around March 14, 2025. The shareholder authorization, if approved,
will be valid for five years.
The Company intends to fund the share repurchases through a
combination of cash generated from operations and drawing debt
funding through its revolving credit facility. The exact number of
shares to be repurchased by the Company under the share repurchase
program, if any, is not guaranteed, including whether the Company
utilizes the full $100 million approved by the Board of Directors.
Depending on market conditions and other factors, and following
receipt of shareholder approval, these repurchases may be commenced
or suspended at any time or periodically without prior notice.
The Company may repurchase shares from time to time on the open
market or in privately negotiated transactions, or otherwise in
accordance with applicable federal securities laws, including Rule
10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as
amended. The timing, manner, price and amount of any repurchases
will be determined by the discretion of management, depending on
market conditions and other factors.
CONFERENCE CALL DETAILS:
The Company will host a conference call at 8:00 am ET today,
February 20, 2025, to review its Q2 FY2025 results. To participate
in Endava’s Q2 FY2025 earnings conference call, please dial in at
least five minutes prior to the scheduled start time (844) 481-2736
or (412) 317-0665 for international participants, Conference ID:
Endava Call.
Investors may listen to the call on Endava’s Investor Relations
website at http://investors.Endava.com. The webcast will be
recorded and available for replay until Thursday March 20,
2025.
ABOUT ENDAVA PLC:
We are a leading provider of next-generation technology
services, dedicated to enabling our customers to drive real impact
and meaningful change. By combining world-class engineering, deep
industry expertise and a customer-centric mindset, we consult and
partner with our customers to create technological solutions that
fuel transformation and empower businesses to succeed in the
AI-driven digital shift. From ideation to production, we support
our customers with tailor-made solutions at every stage of their
digital transformation, regardless of industry, region or
scale.
Endava’s clients span payments, insurance, finance and banking,
technology, media, telecommunications, healthcare and life
sciences, mobility, retail and consumer goods and more. As of
December 31, 2024, 11,668 Endavans are helping clients break new
ground across locations in Europe, the Americas, Asia Pacific and
the Middle East.
NON-IFRS FINANCIAL INFORMATION:
To supplement Endava’s Condensed Consolidated Statements of
Comprehensive Income, Condensed Consolidated Balance Sheets and
Condensed Consolidated Statements of Cash Flows presented in
accordance with IFRS, the Company uses non-IFRS measures of certain
components of financial performance in this press release. These
measures include revenue growth/(decline) rate at constant
currency, adjusted profit before tax, adjusted profit for the
period, adjusted diluted EPS and adjusted free cash flow.
Revenue growth/(decline) rate at constant currency is calculated
by translating revenue from entities reporting in foreign
currencies into British Pounds using the comparable foreign
currency exchange rates from the prior period. For example, the
average currency rates in effect for the fiscal quarter ended
December 31, 2023 were used to convert revenue for the fiscal
quarter ended December 31, 2024 and the revenue for the comparable
prior period.
Adjusted profit before tax ("Adjusted PBT") is defined as the
Company’s profit before tax adjusted to exclude the impact of
share-based compensation expense, amortisation of acquired
intangible assets, realised and unrealised foreign currency
exchange (gains)/losses, net, restructuring costs, and fair value
movement of contingent consideration, all of which are non-cash
items except for realised foreign currency exchange (gains)/losses,
net. Our Adjusted PBT margin is our Adjusted PBT as a percentage of
our total revenue.
Adjusted profit for the period is defined as Adjusted PBT less
the adjusted tax charge for the period. The adjusted tax charge is
the tax charge adjusted for the tax impact of the adjustments to
PBT and the release of the deferred tax liability relating to
Romanian withholding tax.
Adjusted diluted EPS is defined as Adjusted profit for the
period, divided by weighted average number of shares outstanding -
diluted.
Adjusted free cash flow is the Company’s net cash from operating
activities, plus grants received, less net purchases of non-current
assets (tangible and intangible). Adjusted free cash flow is not
intended to be a measure of residual cash available for
management's discretionary use since it omits significant sources
and uses of cash flow, including mandatory debt repayments and
changes in working capital.
Management believes these measures help illustrate underlying
trends in the Company's business and uses the measures to establish
budgets and operational goals, communicated internally and
externally, for managing the Company's business and evaluating its
performance. Management also believes the presentation of its
non-IFRS financial measures enhances an investor’s overall
understanding of the Company’s historical financial performance.
The presentation of the Company’s non-IFRS financial measures is
not meant to be considered in isolation or as a substitute for the
Company’s financial results prepared in accordance with IFRS, and
its non-IFRS measures may be different from non-IFRS measures used
by other companies. Investors should review the reconciliation of
the Company’s non-IFRS financial measures to the comparable IFRS
financial measures included below, and not rely on any single
financial measure to evaluate the Company’s business.
FORWARD-LOOKING STATEMENTS:
This press release includes forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements may be identified by the use
of terms and phrases such as “believe,” “expect,” "intends,"
"outlook," “may,” “will,” and other similar terms and phrases. Such
forward-looking statements include, but are not limited to, the
statements regarding trends with respect to the adoption of
generative AI, the share repurchase program, including Endava's
anticipated receipt of shareholder approval for the share
repurchase program, and management's financial outlook for the
third quarter and full fiscal year 2025. Forward-looking statements
involve known and unknown risks, uncertainties and other factors
that could cause actual results to differ materially from the
results anticipated by these forward-looking statements, including,
but not limited to: Endava’s ability to achieve its revenue growth
goals including as a result of a slower conversion of its pipeline;
Endava's expectations of future operating results or financial
performance; Endava’s ability to accurately forecast and achieve
its announced guidance; Endava's ability to retain existing clients
and attract new clients, including its ability to increase revenue
from existing clients and diversify its revenue concentration;
Endava’s ability to attract and retain highly-skilled IT
professionals at cost-effective rates; Endava's ability to
successfully identify acquisition targets, consummate acquisitions
and successfully integrate acquired businesses and personnel;
Endava's ability to penetrate new industry verticals and
geographies and grow its revenue in current industry verticals and
geographies; Endava’s ability to maintain favorable pricing and
utilization rates to support its gross margin; the effects of
increased competition as well as innovations by new and existing
competitors in its market; the size of Endava's addressable market
and market trends; Endava’s ability to adapt to technological
change and industry trends and innovate solutions for its clients;
Endava's plans for growth and future operations, including its
ability to manage its growth; Endava's ability to effectively
manage its international operations, including Endava's exposure to
foreign currency exchange rate fluctuations; Endava's future
financial performance, including trends in revenue, cost of sales,
gross profit, selling, general and administrative expenses, finance
income and expense and taxes; the impact of unstable market and
economic conditions, including as a result of actual or anticipated
changes in interest rates, economic inflation and the responses by
central banking authorities to control such inflation; and the
impact of political instability, natural disaster, events of
terrorism and wars, including the military conflict between Ukraine
and Russia and related sanctions, as well as other risks and
uncertainties discussed in the “Risk Factors” section of Endava's
Annual Report on Form 20-F for the year ended June 30, 2024 filed
with the SEC on September 19, 2024 and in other filings that Endava
makes from time to time with the SEC. In addition, the
forward-looking statements included in this press release represent
Endava’s views and expectations as of the date hereof and are based
on information currently available to Endava. Endava anticipates
that subsequent events and developments may cause its views to
change. Endava specifically disclaims any obligation to update the
forward-looking statements in this press release except as required
by law. These forward-looking statements should not be relied upon
as representing Endava’s views as of any date subsequent to the
date hereof.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME
Six Months Ended December
31
Three Months Ended December
31
2024
2023(1)
2024
2023
£’000
£’000
£’000
£’000
REVENUE
390,641
371,973
195,589
183,552
Cost of sales
Direct cost of sales
(283,066
)
(259,412
)
(143,546
)
(132,093
)
Allocated cost of sales
(13,898
)
(13,218
)
(7,025
)
(6,586
)
Total cost of sales
(296,964
)
(272,630
)
(150,571
)
(138,679
)
GROSS PROFIT
93,677
99,343
45,018
44,873
Selling, general and administrative
expenses
(87,314
)
(78,618
)
(43,345
)
(40,255
)
OPERATING PROFIT
6,363
20,725
1,673
4,618
Net finance income/(expense)
354
7,193
831
5,987
PROFIT BEFORE TAX
6,717
27,918
2,504
10,605
Tax on profit on ordinary activities
2,381
(7,205
)
4,347
(2,258
)
PROFIT FOR THE PERIOD
9,098
20,713
6,851
8,347
OTHER COMPREHENSIVE INCOME
Items that may be reclassified
subsequently to profit or loss:
Exchange differences on translating
foreign operations and net investment hedge impact
(13,813
)
1,869
9,527
(2,873
)
TOTAL COMPREHENSIVE INCOME/(LOSS) FOR
THE PERIOD ATTRIBUTABLE TO OWNERS OF THE COMPANY
(4,715
)
22,582
16,378
5,474
EARNINGS PER SHARE (EPS):
Weighted average number of shares
outstanding - Basic
59,269,752
58,101,072
59,488,389
58,300,691
Weighted average number of shares
outstanding - Diluted
59,472,250
58,367,296
59,628,436
58,602,535
Basic EPS (£)
0.15
0.36
0.12
0.14
Diluted EPS (£)
0.15
0.35
0.11
0.14
CONDENSED CONSOLIDATED BALANCE SHEETS
December 31, 2024
June 30, 2024
December 31, 2023 (1)
£’000
£’000
£’000
ASSETS - NON-CURRENT
Goodwill
511,647
515,724
254,180
Intangible assets
114,100
127,797
60,818
Property, plant and equipment
16,603
20,638
23,181
Lease right-of-use assets
47,459
53,294
54,949
Deferred tax assets
21,466
18,323
22,084
Financial assets and other receivables
9,005
10,499
6,386
TOTAL
720,280
746,275
421,598
ASSETS - CURRENT
Trade and other receivables
190,059
193,673
172,002
Corporation tax receivable
10,072
11,402
2,127
Financial assets
118
183
186
Cash and cash equivalents
60,065
62,358
198,602
TOTAL
260,314
267,616
372,917
TOTAL ASSETS
980,594
1,013,891
794,515
LIABILITIES - CURRENT
Lease liabilities
14,457
14,450
13,782
Trade and other payables
106,260
116,569
85,347
Corporation tax payable
9,784
8,556
4,565
Contingent consideration
3,577
8,444
5,335
Deferred consideration
4,170
5,840
2,499
TOTAL
138,248
153,859
111,528
LIABILITIES - NON CURRENT
Borrowings
123,669
144,754
—
Lease liabilities
37,711
43,557
45,645
Deferred tax liabilities
24,719
30,814
13,541
Contingent consideration
1,155
—
—
Deferred consideration
—
943
3,280
Other liabilities
377
509
543
TOTAL
187,631
220,577
63,009
EQUITY
Share capital
1,189
1,180
1,167
Share premium
21,280
21,280
17,753
Merger relief reserve
63,440
63,440
48,139
Retained earnings
602,688
573,640
566,589
Other reserves
(33,872
)
(20,059
)
(13,644
)
Investment in own shares
(10
)
(26
)
(26
)
TOTAL
654,715
639,455
619,978
TOTAL LIABILITIES AND EQUITY
980,594
1,013,891
794,515
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended December
31(2)
Three Months Ended December
31(2)
2024
2023
2024
2023
£’000
£’000
£’000
£’000
OPERATING ACTIVITIES
Profit for the period
9,098
20,713
6,851
8,347
Income tax charge
(2,381
)
7,205
(4,347
)
2,258
Non-cash adjustments
46,207
31,833
22,614
16,033
Tax paid
(3,786
)
(4,814
)
(2,466
)
(2,466
)
Net changes in working capital
(12,716
)
(3,314
)
9,396
10,864
Net cash from operating
activities
36,422
51,623
32,048
35,036
INVESTING ACTIVITIES
Purchase of non-current assets (tangibles
and intangibles)
(1,571
)
(2,200
)
(436
)
(1,393
)
Proceeds/(Loss) from disposal of
non-current assets
36
(27
)
—
(30
)
Payment for acquisition of subsidiary, net
of cash acquired
(5,900
)
(6,710
)
(5,832
)
(2,528
)
Other acquisition-related settlements
—
(6,680
)
—
—
Interest received
720
3,522
353
1,957
Net cash used in investing
activities
(6,715
)
(12,095
)
(5,915
)
(1,994
)
FINANCING ACTIVITIES
Proceeds from sublease
64
87
34
31
Proceeds from bank loans
10,000
—
10,000
—
Repayment of borrowings
(30,842
)
—
(23,842
)
—
Repayment of lease liabilities
(6,159
)
(6,295
)
(3,066
)
(2,947
)
Repayment of lease interest
(989
)
(1,125
)
(482
)
(553
)
Interest and debt financing costs paid
(4,282
)
(583
)
(2,030
)
(296
)
Grant received
274
230
—
23
Proceeds from exercise of options
—
3,129
—
3,118
Net cash used in financing
activities
(31,934
)
(4,557
)
(19,386
)
(624
)
Net change in cash and cash
equivalents
(2,227
)
34,971
6,747
32,418
Cash and cash equivalents at the
beginning of the period
62,358
164,703
52,811
168,191
Exchange differences on cash and cash
equivalents
(66
)
(1,072
)
507
(2,007
)
Cash and cash equivalents at the end of
the period
60,065
198,602
60,065
198,602
RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS
FINANCIAL MEASURES
RECONCILIATION OF REVENUE GROWTH/(DECLINE) RATE AS REPORTED
UNDER IFRS TO REVENUE GROWTH/(DECLINE) RATE AT CONSTANT
CURRENCY:
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
REVENUE GROWTH/(DECLINE) RATE AS
REPORTED UNDER IFRS
5.0
%
(7.3
%)
6.6
%
(10.6
%)
Impact of Foreign exchange rate
fluctuations
2.0
%
2.8
%
2.5
%
2.5
%
REVENUE GROWTH/(DECLINE) RATE AT
CONSTANT CURRENCY
7.0
%
(4.5
%)
9.1
%
(8.1
%)
RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED
PROFIT FOR THE PERIOD:
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
£’000
£’000
£’000
£’000
PROFIT BEFORE TAX
6,717
27,918
2,504
10,605
Adjustments:
Share-based compensation expense
21,965
23,556
10,944
13,617
Amortisation of acquired intangible
assets
12,182
7,085
6,036
3,684
Foreign currency exchange (gains)/losses,
net
(3,420
)
2,685
(2,574
)
4,764
Restructuring costs
5,494
—
5,494
—
Fair value movement of contingent
consideration
(1,871
)
(8,706
)
(569
)
(9,942
)
Total adjustments
34,350
24,620
19,331
12,123
ADJUSTED PROFIT BEFORE TAX
41,067
52,538
21,835
22,728
PROFIT FOR THE PERIOD
9,098
20,713
6,851
8,347
Adjustments:
Adjustments to profit before tax
34,350
24,620
19,331
12,123
Release of Romanian withholding tax
(3,800
)
—
(3,800
)
—
Tax impact of adjustments
(6,682
)
(4,916
)
(4,511
)
(2,977
)
ADJUSTED PROFIT FOR THE PERIOD
32,966
40,417
17,871
17,493
RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER
SHARE:
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
£’000
£’000
£’000
£’000
DILUTED EARNINGS PER SHARE (£)
0.15
0.35
0.11
0.14
Adjustments:
Share-based compensation expense
0.37
0.40
0.18
0.23
Amortisation of acquired intangible
assets
0.20
0.12
0.10
0.06
Foreign currency exchange (gains)/losses,
net
(0.06
)
0.05
(0.04
)
0.08
Restructuring costs
0.09
—
0.09
—
Fair value movement of contingent
consideration
(0.02
)
(0.15
)
—
(0.16
)
Release of Romanian withholding tax
(0.06
)
—
(0.06
)
—
Tax impact of adjustments
(0.12
)
(0.08
)
(0.08
)
(0.05
)
Total adjustments
0.40
0.34
0.19
0.16
ADJUSTED DILUTED EARNINGS PER SHARE
(£)
0.55
0.69
0.30
0.30
RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO
ADJUSTED FREE CASH FLOW
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
£’000
£’000
£’000
£’000
NET CASH FROM OPERATING
ACTIVITIES
36,422
51,623
32,048
35,036
Adjustments:
Grant received
274
230
—
23
Net purchase of non-current assets
(tangibles and intangibles)
(1,535
)
(2,227
)
(436
)
(1,423
)
ADJUSTED FREE CASH FLOW
35,161
49,626
31,612
33,636
SUPPLEMENTARY INFORMATION SHARE-BASED COMPENSATION
EXPENSE
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
£’000
£’000
£’000
£’000
Direct cost of sales
15,048
16,318
7,254
9,516
Selling, general and administrative
expenses
6,917
7,238
3,690
4,101
Total
21,965
23,556
10,944
13,617
DEPRECIATION AND AMORTISATION
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
£’000
£’000
£’000
£’000
Direct cost of sales
10,413
10,049
5,233
4,853
Selling, general and administrative
expenses
13,720
8,712
6,823
4,489
Total
24,133
18,761
12,056
9,342
EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT
Six Months Ended December
31
Three Months Ended December
31
2024
2023
2024
2023
Closing number of total employees
(including directors)
11,668
11,539
11,668
11,539
Average operational employees
10,541
10,606
10,456
10,461
Top 10 customers %
34
%
34
%
36
%
34
%
Number of clients with > £1m of
revenue
(rolling 12 months)
141
150
141
150
Geographic split of revenue %
North America
39
%
31
%
39
%
31
%
Europe
24
%
25
%
24
%
26
%
UK
32
%
35
%
32
%
34
%
Rest of World (RoW)
5
%
9
%
5
%
9
%
Industry vertical split of revenue
%
Payments
19
%
27
%
19
%
26
%
Banking and Capital Markets
18
%
14
%
19
%
14
%
Insurance
9
%
8
%
9
%
8
%
TMT
20
%
23
%
19
%
23
%
Mobility
9
%
11
%
9
%
11
%
Healthcare
12
%
4
%
12
%
4
%
Other
13
%
13
%
13
%
14
%
FOOTNOTES
(1) Restated to include the effect of revisions arising from
provisional to final acquisition accounting for DEK and
Mudbath.
(2) The presentation of the Consolidated Statement of Cash Flows
has been changed to separately present the repayment of lease
interest from the total repayments of lease liabilities.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250219465522/en/
INVESTOR CONTACT: Endava plc Laurence Madsen, Head of
Investor Relations Investors@endava.com
Endava (NYSE:DAVA)
Historical Stock Chart
From Feb 2025 to Mar 2025
Endava (NYSE:DAVA)
Historical Stock Chart
From Mar 2024 to Mar 2025
